Swiss National Bank’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $785K | Hold |
227,000
| – | – | ﹤0.01% | 2231 |
|
|
2025
Q1 | $595K | Buy |
227,000
+7,400
| +3% | +$19.4K | ﹤0.01% | 2313 |
|
|
2024
Q4 | $905K | Hold |
219,600
| – | – | ﹤0.01% | 2247 |
|
|
2024
Q3 | $1.55M | Buy |
219,600
+51,800
| +31% | +$367K | ﹤0.01% | 1996 |
|
|
2024
Q2 | $1.09M | Buy |
167,800
+4,300
| +3% | +$28K | ﹤0.01% | 2134 |
|
|
2024
Q1 | $1.36M | Buy |
163,500
+7,100
| +5% | +$58.9K | ﹤0.01% | 2062 |
|
|
2023
Q4 | $1.72M | Sell |
156,400
-17,400
| -10% | -$192K | ﹤0.01% | 1932 |
|
|
2023
Q3 | $1.46M | Buy |
173,800
+2,000
| +1% | +$16.8K | ﹤0.01% | 2024 |
|
|
2023
Q2 | $2.16M | Buy |
171,800
+2,100
| +1% | +$26.4K | ﹤0.01% | 1836 |
|
|
2023
Q1 | $2.79M | Sell |
169,700
-19,000
| -10% | -$313K | ﹤0.01% | 1628 |
|
|
2022
Q4 | $2.82M | Buy |
188,700
+3,800
| +2% | +$56.8K | ﹤0.01% | 1667 |
|
|
2022
Q3 | $4.14M | Buy |
184,900
+31,900
| +21% | +$714K | ﹤0.01% | 1388 |
|
|
2022
Q2 | $2.56M | Buy |
153,000
+50,800
| +50% | +$851K | ﹤0.01% | 1743 |
|
|
2022
Q1 | $3.06M | Buy |
102,200
+8,800
| +9% | +$263K | ﹤0.01% | 1769 |
|
|
2021
Q4 | $2.87M | Buy |
93,400
+21,900
| +31% | +$672K | ﹤0.01% | 1817 |
|
|
2021
Q3 | $2.25M | Buy |
71,500
+1,800
| +3% | +$56.7K | ﹤0.01% | 1981 |
|
|
2021
Q2 | $2.55M | Buy |
69,700
+8,000
| +13% | +$293K | ﹤0.01% | 1946 |
|
|
2021
Q1 | $2.13M | Buy |
61,700
+700
| +1% | +$24.2K | ﹤0.01% | 1962 |
|
|
2020
Q4 | $2.54M | Buy |
+61,000
| New | +$2.54M | ﹤0.01% | 1777 |
|